Next-Generation Antibody-Drug Conjugates Demonstrate Remarkable Potential in Early-Stage Disease
In a groundbreaking development presented at the ESMO Congress 2025, the oncology field witnesses a transformative leap forward with the introduction of next-generation antibody-drug conjugates...















